ARID1B and neoplasm: Finally, we discovered that by suppressing ARID1B function via blocking its nuclear import or via KO of the ARID1B gene in vivo, we not only inhibited tumor growth but also augmented the therapeutic efficacy of PARP inhibitors in treating TNBC tumors.